TELESTA THERAPEUTICS INC T.TST

Bladder cancer early investment opportunity

[high2]

Imagin Medical is developing a bladder cancer detection tool.  They are merging with a listed company and raising funds at $.15 per share..good time to get in early...  this ight be worthy of TST to takeover the proejct    contact  ifno on the current private placement on Imagin is:

Address:	600 - 890 West Pender Street Vancouver, BC Canada V6C 1J9
Telephone:	[phone]
Fax:	[phone]
President: Bill Galine
Email:	[e-mail]
Mobile:	[phone]
Telephone:	[phone] ext. 106

I

 

n the 50’s, we watched black and white TV’s. Now in 2016, we watch HD, color television with picture clarity and depth. It is simply a different experience. By way of analogy, we are bringing this same technological advancement to the urologist looking for bladder cancer.
Imagin Medical is a medical imaging company that believes it will radically improve the way physicians detect cancer through the use of endoscopes to image and visualize cancer and/or cancer markers. Dr. Stavros Demos from the renowned Lawrence Livermore National Laboratory (LLNL) is the inventor of a combination optical/laser technology that uses white light and near-infrared fluorescence for the accurate visual detection of cancer. Dr. Demos worked in collaboration with the UC Davis Comprehensive Cancer Center and Dr. Ralph deVere White, one of the world’s leading authorities on bladder cancer, for more than five years to validate this technology. The Company has entered into a partnership with the LLNL and UC Davis to complete the clinical evaluations that will support the Company’s FDA submission. Imagin holds the exclusive license to this intellectual property.